Literature DB >> 29230494

Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population.

Naiwen Hu1, Yazhou Cui2, Qingrui Yang3, Liya Wang1, Xinglin Yang1, Hongzhi Xu4.   

Abstract

The aim of this study is to investigate the association of the polymorphisms in tumor necrosis factor (TNF) and granulin (GRN) with ankylosing spondylitis (AS) in a Chinese Han population. Five single nucleotide polymorphisms (SNPs) covering TNF and six SNPs covering GRN were investigated in 861 Chinese Han AS patients and 864 healthy controls. For rs1799964, the C allele was linked to reduced risk of AS (p < 0.0001, OR = 0.60, 95% CI = 0.50-0.71). The carriers of the C/C homozygote showed a significantly lower risk of AS compared with the TT homozygote and the C/T heterozygote under the recessive model (p < 0.0001, OR = 0.23, 95% CI = 0.12-0.45). For rs1800629, the A allele was also linked to reduced risk of AS (p < 0.0001, OR = 0.54, 95% CI = 0.39-0.74). For rs1800630, the A allele was also linked to reduced risk of AS (p < 0.0001, OR = 0.59, 95% CI = 0.48-0.72). The carriers of the A/A homozygote showed a significantly lower risk of AS compared with the C/C homozygote and the A/C heterozygote under the recessive model (p < 0.0001, OR = 0.18, 95% CI = 0.07-0.47). For rs769178, the T allele was linked to increased risk of AS (p < 0.0001, OR = 2.59, 95% CI = 2.18-3.09). The carriers of the T/T homozygote showed a significantly higher risk of AS compared with the GG homozygote and the G/T heterozygote under the recessive model (p < 0.0001, OR = 3.34, 95 %CI = 1.95-5.72). There was no significant difference between the AS patients and the controls in the genotype or allele frequencies of rs361525. For GRN, there was no significant difference between the AS patients and the controls in the genotype or allele frequencies of rs25646, rs3760365, rs3785817, rs4792939, rs5848, rs850713 (p > 0.05). This study indicates that polymorphisms in TNF are related to AS, but polymorphisms in GRN are not related to AS susceptibility in a Chinese Han population.

Entities:  

Keywords:  Ankylosing spondylitis; GRN; Single nucleotide polymorphisms; TNF

Mesh:

Substances:

Year:  2017        PMID: 29230494     DOI: 10.1007/s00296-017-3899-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  SNPs in the TNF-α gene promoter associated with Behcet's disease in Moroccan patients.

Authors:  Asmaa Radouane; Mounia Oudghiri; Abdelfettah Chakib; Siham Bennani; Isabelle Touitou; Mouna Barat-Houari
Journal:  Rheumatology (Oxford)       Date:  2012-06-17       Impact factor: 7.580

Review 2.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

3.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

4.  Tumor necrosis factor-α promoter -308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-α and does not predict TNF inhibitor response.

Authors:  Johannes C Nossent; Sylvia Sagen-Johnsen; Gunnstein Bakland
Journal:  J Rheumatol       Date:  2014-07-15       Impact factor: 4.666

5.  Progranulin antibodies in autoimmune diseases.

Authors:  Lorenz Thurner; Klaus-Dieter Preuss; Natalie Fadle; Evi Regitz; Philipp Klemm; Marina Zaks; Maria Kemele; Andrea Hasenfus; Elena Csernok; Wolfgang L Gross; Jean-Louis Pasquali; Thierry Martin; Rainer Maria Bohle; Michael Pfreundschuh
Journal:  J Autoimmun       Date:  2012-11-11       Impact factor: 7.094

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 7.  Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.

Authors:  Johanna Callhoff; Joachim Sieper; Anja Weiß; Angela Zink; Joachim Listing
Journal:  Ann Rheum Dis       Date:  2014-04-09       Impact factor: 19.103

8.  The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.

Authors:  Wei Tang; Yi Lu; Qing-Yun Tian; Yan Zhang; Feng-Jin Guo; Guang-Yi Liu; Nabeel Muzaffar Syed; Yongjie Lai; Edward Alan Lin; Li Kong; Jeffrey Su; Fangfang Yin; Ai-Hao Ding; Alexandra Zanin-Zhorov; Michael L Dustin; Jian Tao; Joseph Craft; Zhinan Yin; Jian Q Feng; Steven B Abramson; Xiu-Ping Yu; Chuan-ju Liu
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

9.  A novel gene variation of TNFalpha associated with ankylosing spondylitis: a reconfirmed study.

Authors:  Xiaoquan Zhu; Yawen Wang; Liang Sun; Yuguo Song; Fei Sun; Lei Tang; Zhenghao Huo; Jianxin Li; Ze Yang
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

10.  Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis.

Authors:  Lorenz Thurner; Marina Zaks; Klaus-Dieter Preuss; Natalie Fadle; Evi Regitz; Mei Fang Ong; Michael Pfreundschuh; Gunter Assmann
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more
  5 in total

Review 1.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

2.  TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging.

Authors:  Pavel Davizon-Castillo; Brandon McMahon; Sonia Aguila; David Bark; Katrina Ashworth; Ayed Allawzi; Robert A Campbell; Emilie Montenont; Travis Nemkov; Angelo D'Alessandro; Nathan Clendenen; Lauren Shih; Natalie A Sanders; Kelly Higa; Allaura Cox; Zavelia Padilla-Romo; Giovanni Hernandez; Eric Wartchow; George D Trahan; Eva Nozik-Grayck; Kenneth Jones; Eric M Pietras; James DeGregori; Matthew T Rondina; Jorge Di Paola
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

3.  The Associations of rs1799724 and rs361525 With the Risk of Ankylosing Spondylitis Are Dependent on HLA-B27 Status in a Chinese Han Population.

Authors:  Nan Sheng; Yingying Gao; Hui Li; Wenwen Wang; Linyu Geng; Bo Zhang; Qiang Huang; Xueqin Wang; Lingyun Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

4.  Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis.

Authors:  Ziran Wang; Lingjun Kong; Han Zhang; Fengchun Sun; Zijian Guo; Rui Zhang; Yaling Dou
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 5.  A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Authors:  Masoud Mahdinejad-Yazdi; Mohammad Reza Sobhan; Seyed Alireza Dastgheib; Reza Bahrami; Seyed Hossein Shaker; Hamid Mirjalili; Jalal Sadeghizadeh-Yazdi; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.